A previous meta-analysis reported that the risk of breast cancer was reduced by about 50% in carriers of BRCA1 and BRCA2 mutations who underwent risk-reducing bilateral salpingo-oophorectomy (RRSO) (13). The gene discussed is BRCA1; the disease is breast cancer.